Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
NRx Pharmaceuticals, Inc. (NRXP) had Pre-Tax Income of $-25.13M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-25.13M |
|
-- |
|
-- |
|
$18.50M |
|
$-18.50M |
|
$-6.62M |
|
|
Pre-Tax Income |
$-25.13M |
$-25.13M |
|
$-25.13M |
|
$-25.13M |
|
$-25.13M |
|
$-25.13M |
|
$-18.50M |
|
$-18.50M |
|
10.64M |
|
10.64M |
|
$-2.36 |
|
$-2.36 |
|
| Balance Sheet Financials | |
$3.30M |
|
-- |
|
$0.35M |
|
$3.65M |
|
$21.86M |
|
$5.01M |
|
$5.01M |
|
$26.87M |
|
$-23.22M |
|
$-23.22M |
|
$-23.22M |
|
14.59M |
|
| Cash Flow Statement Financials | |
$-10.64M |
|
-- |
|
$7.49M |
|
$4.59M |
|
$1.44M |
|
$-3.15M |
|
$0.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.15 |
|
-- |
|
-- |
|
-0.28 |
|
-0.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
108.19% |
|
108.19% |
|
-688.20% |
|
137.96% |
|
$-1.59 |
|
$-1.00 |
|
$-1.00 |
|